Resveratrol: Biological Activities and Therapeutic Potential
Journal Title: JOURNAL OF PHARMACEUTICAL TECHNOLOGY, RESEARCH AND MANAGEMENT - Year 2014, Vol 2, Issue 2
Abstract
Resveratrol is a polyphenolic flavonoid initially identified as a phytoalexin and as a major constituent of red wine. However interest in this molecule initially developed as a cardioprotective agent and in due course of time therapeutic actions came into limelight. This article explores the different therapeutic activities of Resveratrol and highlights their possible mode of action responsible for its therapeutic action. It becomes evident from this article that Resveratrol has a pharmacological agent that has widespread targets and therefore due emphasis on specific biological action need to be addressed using medicinal chemistry and quantitative structure activity relationships in developing new congeners of Resveratrol to be exploited as drugs.
Authors and Affiliations
Sanjai Saxena , Anugya Srivastava
Keywords
Related Articles
- EP ID EP596690
- DOI 10.15415/jptrm.2014.22010
- Views 156
- Downloads 0
Standardization of Some Commercial Anti-diabetic Herbal Products containing Syzygiumcumini
An isocratic HPLC method was developed for standardization of five commercially available products containing S. cumini seeds (DIABECON, MADHULENE, HYPONIDD, D-FIT and DIABEGON)using methylxanthoxylin (MXX)as marker. The...
Cytoprotective Activity of Adhatoda Vasica Extract and Vasicine Against Tobacco Smoke Induced Cytoxicity
The present study was undertaken to investigate the protection against cytotoxicity due to tobacco smoke by Adhatoda vasica and Vasicine. The antioxidant potential of AVE was analyzed through in vitro assays. The protect...
Pharmacognostic Standardization of Biophytum Sensitivum Dc
Biophytum sensitivum DC. (Family – Oxalidaceae) is a traditional drug used in treating various ailments especially in mental disorders. The present study was envisaged to establish pharmacognostic standards of the plant...
A Review on Role of Advanced Glycation End products (AGEs) in Rheumatoid Arthritis
Rheumatoid arthritis (RAa) is a systemic inflammatory connective tissue disease with polyarthritis as a prominent feature; however, extra-articular symptoms and signs are always present. Aadvanced glycation end products...
Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorders
Epigenetic modification acetylation or deacetylation of histone considered as an important element in various disorders. Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are the enzymes which catalyse t...